Minimal residual disease (MRD) refers to a chemotherapy/radiotherapy-surviving leukemia
cell population that gives rise to relapse of the disease. The detection of MRD is critical for …

Lymphoblastic lymphoma (LBL) is the second most common type of Non‐Hodgkin
Lymphoma (NHL) in childhood and adolescence, accounting for 25–35% of all cases. The …

ANPELA is widely used for quantifying traditional bulk proteomic data. Recently, there is a
clear shift from bulk proteomics to the single‐cell ones (SCP), for which powerful cytometry …

Background While it is known that CD123 is normally strongly expressed on plasmacytoid
dendritic cells and completely absent on nucleated red blood cells, detailed information …

PURPOSE Infant acute lymphoblastic leukemia (ALL) is characterized by a high incidence of
KMT2A gene rearrangements and poor outcome. We evaluated the value of minimal …

Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) is a distinct subtype of T
lymphoblastic leukemia (T-ALL) identified in 2009, due to its unique immunophenotypic and …

Despite attempts to improve the definitions of ambiguous lineage leukemia (ALAL) during
the last 2 decades, general therapy recommendations are missing. Herein, we report a large …

Simple Summary Studies conducted in a recent decade revealed that acute lymphoblastic
leukemia cells exploit various mechanisms to avoid immune recognition and destruction by …

Recently, we described B-cell precursor acute lymphoblastic leukemia (BCP-ALL) subtype
with an early switch to the monocytic lineage and the loss of the B-cell immunophenotype …

Lymphoblastic lymphoma (LBL) is the second most common type of non-Hodgkin
Lymphoma (NHL) in children, adolescents, and young adults (CAYA), accounting for 25 …